These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11098257)

  • 1. SSRIs for vasodepressor syncope?
    Grubb BP
    Postgrad Med; 2000 Nov; 108(6):29, 32. PubMed ID: 11098257
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants for fainting spells.
    Harv Heart Lett; 1999 Sep; 10(1):3. PubMed ID: 10445969
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of pathophysiology and therapy of patients with vasovagal syncope.
    White CM; Tsikouris JP
    Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.
    Grubb BP; Karas BJ
    J Interv Card Electrophysiol; 1998 Dec; 2(4):325-32. PubMed ID: 10027117
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 9. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasovagal syncope: asystole provoked by head-up tilt testing under sertraline therapy.
    Lenk MK; Alehan D; Ozme S; Celiker A; Ozer S
    Turk J Pediatr; 1997; 39(4):573-7. PubMed ID: 9433163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of neurocardiogenic syncope.
    Nair N; Padder FA; Kantharia BK
    Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can I do when first-line measures are not enough for vasovagal syncope?
    Hutt Centeno E; Mayuga KA
    Cleve Clin J Med; 2018 Dec; 85(12):920-922. PubMed ID: 30526751
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of vasovagal syncope.
    Parry SW; Kenny RA
    QJM; 1999 Dec; 92(12):697-705. PubMed ID: 10581332
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.